CRANFORD, N.J., Oct. 17, 2019 /PRNewswire/ -- Atlantis Healthcare, a pioneer and global leader in health psychology-based patient support programs, was named a Trailblazer 2019 Gold Award winner for Best Persistence/Adherence program by PM360, a leading trade magazine for the pharmaceutical, biotech, medical device and diagnostics industries. The PM

ROCKVILLE, Md., Oct. 17, 2019 /PRNewswire/ -- DrFirst, the nation's leading provider of e-prescribing, patient medication management, and price transparency solutions, expanded its partnership with

THC.CSE THCBF.OTC TFHC.F VANCOUVER, Oct. 17, 2019 /PRNewswire/ - THC BioMed Intl Ltd. ("THC BioMed") (CSE: THC) announces that is has submitted its application to Health Canada to amended its licence to add sales of cannabis edibles, topicals and extracts."THC BioMed has always been focused on producing

MISSISSAUGA, ON, Oct. 17, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it intends to release its third quarter 2019 financial results before markets open on Thursday, October 31,

BALTIMORE, Oct. 17, 2019 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, will announce financial results for the third quarter ended September 30, 2019 on Thursday, November 7, 2019, after market close. The Company will

FREMONT, Calif., Oct. 17, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced the availability of the Thermo Scientific Acrometrix BCR-ABL Panel, its latest molecular quality control panel. The Acrometrix BCR-ABL Panel is intended for use as an external control panel for analytical validation of BCR-ABL test methods.

NEW YORK and CAESAREA, Israel, Oct. 17, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp. (NASDAQ: DRIO) today announced it will release its third quarter 2019 results on Monday, October 28

DOVER, Delaware, Oct. 17, 2019 /PRNewswire/ -- CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Vertebral Body Replacement (VBR) System to replace a collapsed, damaged, or unstable vertebral body due to tumor or trauma. The CarboClear® VBR

MILAN and MUNICH and MENLO PARK, Calif., Oct. 17, 2019 /PRNewswire/ -- Breath Therapeutics, a Zambon company, a biopharmaceutical company specializing in advanced inhaled therapeutics for severe respiratory diseases with high unmet medical need, today announced presentations at three upcoming s

PORTLAND, Ore., Oct. 17, 2019 /PRNewswire/ -- Social CBD (www.thesocialcbd.com), the wellness company providing high-quality, lab-tested and certified CBD solutions, to